
Spring Mountain Capital
Description
Spring Mountain Capital (SMC) is a New York-based private investment management firm with approximately $1.5 billion in assets under management. The firm primarily focuses on its Growth Equity strategy, targeting promising enterprise technology and healthcare companies across North America. SMC aims to partner with businesses that have demonstrated strong market traction and are poised for significant expansion.
Under its Growth Equity arm, SMC seeks out established companies with proven business models, robust revenue streams, and experienced management teams. They typically invest in businesses generating annual revenues between $5 million and $50 million, providing capital to fuel initiatives such as market expansion, new product development, or strategic acquisitions. The firm emphasizes a partnership approach, working closely with founders and management to navigate growth challenges and capitalize on market opportunities.
SMC's typical initial investment in growth equity rounds ranges from $10 million to $30 million. This capital is deployed to support companies that are past the early-stage venture phase and require substantial funding to scale operations and accelerate their growth trajectory. Their investment philosophy centers on identifying companies with defensible market positions and clear paths to profitability and market leadership.
Beyond financial investment, Spring Mountain Capital offers strategic guidance and operational expertise, leveraging its extensive network and deep industry knowledge. The firm is committed to long-term partnerships, providing the resources and support necessary for its portfolio companies to achieve sustainable growth and maximize shareholder value.
Investor Profile
Spring Mountain Capital has backed more than 52 startups, with 3 new investments in the last 12 months alone. The firm has led 31 rounds, about 60% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Led 2 rounds in the past year.
- Typical check size: $10M – $30M.
Stage Focus
- Series B (38%)
- Series A (33%)
- Series C (13%)
- Seed (6%)
- Series Unknown (4%)
- Private Equity (4%)
- Post Ipo Equity (2%)
Country Focus
- United States (90%)
- Canada (6%)
- Switzerland (2%)
- China (2%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Enterprise Software
- Medical
- Medical Device
- Information Technology
- Analytics
- Therapeutics
- Cyber Security
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.